The First Clinical Trial of Bacteriophage Therapy in Patients wtih Acne Vulgaris

Phase 1

Recruiting

• Conditions: Acne Vulgaris; Acne; D000152

• Registration Number: JPRN-jRCTs051230164
• Lead Sponsor: Tsuruta Daisuke

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-01-12
• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

1)Patients diagnosed with acne vulgaris
2)One or more acne vulgaris skin rashes (noninflammatory or inflammatory)
3)12 years old over (Both of male and female)
4)Written informed consent by his or her own will

Exclusion Criteria

1) Abnormal skin findings (e.g., erosions, ulcers, etc.) at the site of topical application of the study drug that are judged by the principal investigator or subinvestigator to preclude topical application of the study drug
2) Plans for excessive sun exposure or artificial tanning (e.g., esthetic salon)
3) Ineligible to participate in this clinical study due to participation in other clinical trials or clinical studies
4) Has a history of hypersensitivity (e.g., contact dermatitis) to the study drug or its components
5) Pregnant, possibly pregnant or breast feeding and hope to get pregnant during this study
6)The physicians consider that the patients are inappropriate for this study

Study & Design

• Study Type: Interventional
• Study Design: Not specified